4Yuen MF, Sablon E, Hui CK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin lnfee Dis, 2003, 36: 979-984.
5Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end stage liver disease. Flepatology, 2001, 33: 464-470.
6Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost, 2006, 4: 717-720.
7Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicling prognosis in patients with liver cirrhosis and is correlaled with residual liver function: a European study. Gut, 2003, 52: 134-139.
8Trotter JF, Brimhall B, Arjal R, et al. Specific laboratory meth-odologies achieve higher model for end stage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl, 2004, 10, 995-1000.
9Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis inpatients with liver cirrhosis an discor related with residual liver function: a European study. Gut, 2003,52 : 134-139.
10Pauwels A, Mostefa-Kaca N, Florent C, et al. Emergency liver transplantation for acute liver failure. Evaluation of London and clichy Criteria. Hepatology, 1993,17 : 124-127.
